Sun Pharmaceutical Industries has raised its shareholding in Zenotech Laboratories from 46.85% of pre rights issue capital to 57.56% of the post rights issue capital.
This is pursuant to allotment of 1,90,00,000 equity shares of Rs 10 each for cash at a price of Rs 45 each including a share premium of Rs 35 per equity share issued on rights basis by Zenotech.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1881.70 |
| Dr. Reddys Lab | 1288.20 |
| Cipla | 1340.70 |
| Zydus Lifesciences | 943.75 |
| Lupin | 2252.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: